C07D 239/24
Having three or more double bonds between ring members or between ring
Official title: having three or more double bonds between ring members or between ring members and non-ring members
C07D239/24 (Having three or more double bonds between ring members or between ring) appears on 8,336 US grants and 7,155 published applications in this corpus.
Search patents in C07D- Granted patents
- 8,336
- Published applications
- 7,155
- Assignees
- 2,550
- Inventors
- 20,755
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 88 | 0 |
| 1977 | 62 | 0 |
| 1978 | 73 | 0 |
| 1979 | 56 | 0 |
| 1980 | 77 | 0 |
| 1981 | 87 | 0 |
| 1982 | 68 | 0 |
| 1983 | 71 | 0 |
| 1984 | 91 | 0 |
| 1985 | 117 | 0 |
| 1986 | 113 | 0 |
| 1987 | 114 | 0 |
| 1988 | 113 | 0 |
| 1989 | 131 | 0 |
| 1990 | 150 | 0 |
| 1991 | 142 | 0 |
| 1992 | 147 | 0 |
| 1993 | 162 | 0 |
| 1994 | 165 | 0 |
| 1995 | 160 | 0 |
| 1996 | 149 | 0 |
| 1997 | 180 | 0 |
| 1998 | 176 | 0 |
| 1999 | 159 | 0 |
| 2000 | 143 | 0 |
| 2001 | 175 | 28 |
| 2002 | 187 | 167 |
| 2003 | 165 | 261 |
| 2004 | 154 | 310 |
| 2005 | 132 | 306 |
| 2006 | 182 | 278 |
| 2007 | 154 | 274 |
| 2008 | 144 | 286 |
| 2009 | 188 | 329 |
| 2010 | 216 | 347 |
| 2011 | 204 | 316 |
| 2012 | 259 | 301 |
| 2013 | 288 | 313 |
| 2014 | 304 | 353 |
| 2015 | 330 | 380 |
| 2016 | 278 | 352 |
| 2017 | 329 | 363 |
| 2018 | 275 | 288 |
| 2019 | 240 | 267 |
| 2020 | 235 | 296 |
| 2021 | 172 | 271 |
| 2022 | 195 | 258 |
| 2023 | 151 | 270 |
| 2024 | 148 | 231 |
| 2025 | 142 | 171 |
| 2026 | 95 | 139 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Crystalline forms of a BTK inhibitor6 Oct 2026US 12,751,949 B2Novartis AG
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- An organic compound and an organic electroluminescent device using the same1 Oct 2026US 2026/0297034 A1Solus Advanced Materials Co., Ltd.
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Most cited
By later US patents
- Pyrimidine, cyanoguanidines as K-channel blockers1,019US 5,633,374 AThe Upjohn Company · 1997
- Pyrimidine derivatives for labeled binding partners639US 5,502,177 AGilead Sciences, Inc. · 1996
- Pyrimidine derivatives488US 6,005,096 AGilead Sciences, Inc. · 1999
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates468US 5,700,920 ANovartis AG · 1997
- Pyrimidine derivatives for labeled binding partners456US 5,763,588 AGilead Sciences, Inc. · 1998